These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15645699)

  • 1. Pubertal changes in serum leptin levels in adolescents with type 1 diabetes mellitus: a controlled longitudinal study.
    Myers SE; Albert SG; Haas MJ; Clifton D; Mooradian AD
    J Pediatr Endocrinol Metab; 2004 Dec; 17(12):1653-62. PubMed ID: 15645699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum leptin levels in children with type 1 diabetes mellitus: contribution of age, BMI, pubertal development and metabolic status.
    Luna R; Garcia-Mayor RV; Lage M; Andrade MA; Barreiro J; Pombo M; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):603-10. PubMed ID: 10594521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index.
    Kiess W; Anil M; Blum WF; Englaro P; Juul A; Attanasio A; Dötsch J; Rascher W
    Eur J Endocrinol; 1998 May; 138(5):501-9. PubMed ID: 9625360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin levels and body composition in children and adolescents with type 1 diabetes.
    Karagüzel G; Ozdem S; Boz A; Bircan I; Akçurin S
    Clin Biochem; 2006 Aug; 39(8):788-93. PubMed ID: 16624268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leptin concentration and insulin sensitivity in type 1 diabetic children and adolescents].
    Szadkowska A; Wyka K; Młynarski W; Pietrzak I; Mianowska B; Bodalski J
    Pediatr Endocrinol Diabetes Metab; 2007; 13(4):194-200. PubMed ID: 18042314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus.
    Wędrychowicz A; Stec M; Sztefko K; Starzyk JB
    Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):491-5. PubMed ID: 24918536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum soluble leptin receptor levels in children and adolescents with type 1 diabetes mellitus.
    Kratzsch J; Deimel A; Galler A; Kapellen T; Klinghammer A; Kiess W
    Eur J Endocrinol; 2004 Oct; 151(4):475-81. PubMed ID: 15476448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone.
    Blum WF; Englaro P; Hanitsch S; Juul A; Hertel NT; Müller J; Skakkebaek NE; Heiman ML; Birkett M; Attanasio AM; Kiess W; Rascher W
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2904-10. PubMed ID: 9284717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of plasma leptin in predicting future weight gain in obese children: a two-and-a-half-year longitudinal study.
    Savoye M; Dziura J; Castle J; DiPietro L; Tamborlane WV; Caprio S
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):942-6. PubMed ID: 12080447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy.
    Öberg D; Salemyr J; Örtqvist E; Juul A; Bang P
    Pediatr Diabetes; 2018 Aug; 19(5):972-978. PubMed ID: 29663652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating acylated and total ghrelin and galanin in children with insulin-treated type 1 diabetes: relationship to insulin therapy, metabolic control and pubertal development.
    Celi F; Bini V; Papi F; Santilli E; Ferretti A; Mencacci M; Berioli MG; De Giorgi G; Falorni A
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):139-45. PubMed ID: 16060906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of anticancer treatment on leptin level, fat body mass (FM) and lean body mass (LBM)].
    Krawczyk-Rybak M; Muszyńska-Rosłan K; Konstantynowicz J; Solarz E; Wołczynski S; Protas P
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):297-307. PubMed ID: 15738606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoleptinemia in female and male elite gymnasts.
    Weimann E; Blum WF; Witzel C; Schwidergall S; Böhles HJ
    Eur J Clin Invest; 1999 Oct; 29(10):853-60. PubMed ID: 10583427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally.
    Gunczler P; Lanes R; Paz-Martinez V; Martins R; Esaa S; Colmenares V; Weisinger JR
    J Pediatr Endocrinol Metab; 1998; 11(3):413-9. PubMed ID: 11517957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D).
    Wędrychowicz A; Sztefko K; Starzyk JB
    Bone; 2019 Mar; 120():387-392. PubMed ID: 30120991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of serum leptin and insulin-like growth factor-1 levels to intima-media thickness and functions of common carotid artery in children and adolescents with type 1 diabetes.
    Atabek ME; Kurtoglu S; Demir F; Baykara M
    Acta Paediatr; 2004 Aug; 93(8):1052-7. PubMed ID: 15456195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
    Acerini CL; Clayton KL; Hintz R; Baker B; Watts A; Holly JM; Dunger DB
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutional delay in growth and puberty (CDGP) is associated with hypoleptinaemia.
    Gill MS; Hall CM; Tillmann V; Clayton PE
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):721-6. PubMed ID: 10468943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.